Editor's choice

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study
Won Park, Pawel Hrycaj, Slawomir Jeka, Volodymyr Kovalenko, Grygorii Lysenko, Pedro Miranda, Helena Mikazane, Sergio Gutierrez-Ureña, MieJin Lim, Yeon-Ah Lee, Sang Joon Lee, HoUng Kim, Dae Hyun Yoo, Jürgen Braun

Annals of the Rheumatic Diseases Oct 2013, 72 (10) 1605-1612; DOI: 10.1136/annrheumdis-2012-203091
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
Dae Hyun Yoo, Pawel Hrycaj, Pedro Miranda, Edgar Ramiterre, Mariusz Piotrowski, Sergii Shevchuk, Volodymyr Kovalenko, Nenad Prodanovic, Mauricio Abello-Banfi, Sergio Gutierrez-Ureña, Luis Morales-Olazabal, Michael Tee, Renato Jimenez, Omid Zamani, Sang Joon Lee, HoUng Kim, Won Park, Ulf Müller-Ladner

Annals of the Rheumatic Diseases Oct 2013, 72 (10) 1613-1620; DOI: 10.1136/annrheumdis-2012-203090
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
Gerd R Burmester, Michael E Weinblatt, Iain B McInnes, Duncan Porter, Olga Barbarash, Mykola Vatutin, Istvan Szombati, Ehsanollah Esfandiari, Matthew A Sleeman, Christopher D Kane, Guy Cavet, Bing Wang, Alex Godwood, Fabio Magrini, for the EARTH Study Group

Annals of the Rheumatic Diseases Sep 2013, 72 (9) 1445-1452; DOI: 10.1136/annrheumdis-2012-202450
A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate
Mark C Genovese, Eric Lee, Julie Satterwhite, Melissa Veenhuizen, Damon Disch, Pierre-Yves Berclaz, Stephen Myers, Gregory Sides, Olivier Benichou

Annals of the Rheumatic Diseases Sep 2013, 72 (9) 1453-1460; DOI: 10.1136/annrheumdis-2012-202864
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors
Mark C Genovese, Roy M Fleischmann, Maria Greenwald, Julie Satterwhite, Melissa Veenhuizen, Li Xie, Pierre-Yves Berclaz, Stephen Myers, Olivier Benichou

Annals of the Rheumatic Diseases Sep 2013, 72 (9) 1461-1468; DOI: 10.1136/annrheumdis-2012-202775
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
Marie B Condon, Damien Ashby, Ruth J Pepper, H Terence Cook, Jeremy B Levy, Megan Griffith, Tom D Cairns, Liz Lightstone

Annals of the Rheumatic Diseases Aug 2013, 72 (8) 1280-1286; DOI: 10.1136/annrheumdis-2012-202844
Trends in the first decade of 21st century healthcare utilisation in a rheumatoid arthritis cohort compared with the general population
Sofia Hagel, Ingemar F Petersson, Ann Bremander, Elisabet Lindqvist, Charlotte Bergknut, Martin Englund

Annals of the Rheumatic Diseases Jul 2013, 72 (7) 1212-1216; DOI: 10.1136/annrheumdis-2012-202571
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
Joachim Sieper, Désirée van der Heijde, Maxime Dougados, Philip J Mease, Walter P Maksymowych, Matthew A Brown, Vipin Arora, Aileen L Pangan

Annals of the Rheumatic Diseases Jun 2013, 72 (6) 815-822; DOI: 10.1136/annrheumdis-2012-201766
Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial
In-Ho Song, Anja Weiß, Kay-Geert A Hermann, Hildrun Haibel, Christian E Althoff, Denis Poddubnyy, Joachim Listing, Ekkehard Lange, Bruce Freundlich, Martin Rudwaleit, Joachim Sieper

Annals of the Rheumatic Diseases Jun 2013, 72 (6) 823-825; DOI: 10.1136/annrheumdis-2012-202389
A novel disease-modifying osteoarthritis drug candidate targeting Runx1
Fumiko Yano, Hironori Hojo, Shinsuke Ohba, Atsushi Fukai, Yoko Hosaka, Toshiyuki Ikeda, Taku Saito, Makoto Hirata, Hirotaka Chikuda, Tsuyoshi Takato, Hiroshi Kawaguchi, Ung-il Chung

Annals of the Rheumatic Diseases May 2013, 72 (5) 748-753; DOI: 10.1136/annrheumdis-2012-201745

Main menu

Editor's choice

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Editor's choice

Pages